Open AccessDectiSomes: Glycan Targeting of Liposomal Drugs Improves the Treatment of Disseminated Candidiasis
Author(s) -
Suresh Ambati,
Tuyetnhu Pham,
Zachary A. Lewis,
Xiaorong Lin,
Richard B. Meagher
Publication year - 2022
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.01467-21
Subject(s) - candida albicans , glycan , immune system , medicine , liposome , anti infective agents , invasive candidiasis , immunology , pharmacology , antifungal , intensive care medicine , biology , microbiology and biotechnology , antimicrobial , fluconazole , dermatology , glycoprotein , biochemistry
Candida albicans causes life-threatening disseminated candidiasis. Individuals at greatest risk have weakened immune systems.